Comparison of dual-echo DSC-MRI- and DCE-MRI-derived contrast agent kinetic parameters.

The application of dynamic susceptibility contrast (DSC) MRI methods to assess brain tumors is often confounded by the extravasation of contrast agent (CA). Disruption of the blood-brain barrier allows CA to leak out of the vasculature leading to additional T(1), T(2) and T(2) relaxation effects in the extravascular space, thereby affecting the signal intensity time course in a complex manner. The goal of this study was to validate a dual-echo DSC-MRI approach that separates and quantifies the T(1) and T(2) contributions to the acquired signal and enables the estimation of the volume transfer constant, K(trans), and the volume fraction of the extravascular extracellular space, v(e). To test the validity of this approach, DSC-MRI- and dynamic contrast enhanced (DCE) MRI-derived K(trans) and v(e) estimates were spatially compared in both 9L and C6 rat brain tumor models. A high degree of correlation (concordance correlation coefficients >0.83, Pearson's r>0.84) and agreement was found between the DSC-MRI- and DCE-MRI-derived measurements. These results indicate that dual-echo DSC-MRI can be used to simultaneously extract reliable DCE-MRI kinetic parameters in brain tumors in addition to conventional blood volume and blood flow metrics.

[1]  Thomas E Yankeelov,et al.  Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. , 2007, Magnetic resonance imaging.

[2]  M V Knopp,et al.  Dynamic contrast-enhanced magnetic resonance imaging in oncology. , 2001, Topics in magnetic resonance imaging : TMRI.

[3]  M. Viergever,et al.  Measurement of cerebral perfusion with dual‐echo multi‐slice quantitative dynamic susceptibility contrast MRI , 1999 .

[4]  Robert C Brasch,et al.  Dynamic contrast‐enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti‐angiogenic therapy in a xenograft model of glioblastoma multiforme , 2002, Journal of magnetic resonance imaging : JMRI.

[5]  J W Belliveau,et al.  Ultrafast imaging of brain tumors , 1993, Topics in magnetic resonance imaging : TMRI.

[6]  Susan M. Chang,et al.  Dynamic susceptibility contrast perfusion imaging of radiation effects in normal‐appearing brain tissue: Changes in the first‐pass and recirculation phases , 2005, Journal of magnetic resonance imaging : JMRI.

[7]  Kim Mouridsen,et al.  T1- and T*2-Dominant Extravasation Correction in DSC-MRI: Part I—Theoretical Considerations and Implications for Assessment of Tumor Hemodynamic Properties , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  M A Viergever,et al.  Simultaneous quantitative cerebral perfusion and Gd‐DTPA extravasation measurement with dual‐echo dynamic susceptibility contrast MRI , 2000, Magnetic resonance in medicine.

[9]  Thomas E Yankeelov,et al.  New insights into tumor microstructure using temporal diffusion spectroscopy. , 2008, Cancer research.

[10]  A P Pathak,et al.  Utility of simultaneously acquired gradient‐echo and spin‐echo cerebral blood volume and morphology maps in brain tumor patients , 2000, Magnetic resonance in medicine.

[11]  Scott D Rand,et al.  The effect of brain tumor angiogenesis on the in vivo relationship between the gradient‐echo relaxation rate change (ΔR2*) and contrast agent (MION) dose , 2003, Journal of magnetic resonance imaging : JMRI.

[12]  David L Buckley,et al.  Transcytolemmal water exchange and its affect on the determination of contrast agent concentration in vivo , 2002, Magnetic resonance in medicine.

[13]  Leif Østergaard,et al.  Principles of cerebral perfusion imaging by bolus tracking , 2005, Journal of magnetic resonance imaging : JMRI.

[14]  S Sourbron,et al.  Bolus‐tracking MRI with a simultaneous T1‐ and T  2* ‐measurement , 2009, Magnetic resonance in medicine.

[15]  Y Yonekura,et al.  Blood volume of gliomas determined by double-echo dynamic perfusion-weighted MR imaging: a preliminary study. , 2001, AJNR. American journal of neuroradiology.

[16]  I. Ercan,et al.  High-grade and low-grade gliomas: differentiation by using perfusion MR imaging. , 2005, Clinical radiology.

[17]  W. Rooney,et al.  Determination of the MRI contrast agent concentration time course in vivo following bolus injection: Effect of equilibrium transcytolemmal water exchange , 2000, Magnetic resonance in medicine.

[18]  Daniel B Kopans,et al.  Breast cancer: regional blood flow and blood volume measured with magnetic susceptibility-based MR imaging--initial results. , 2002, Radiology.

[19]  M. Essig,et al.  Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy. , 2001, International journal of radiation oncology, biology, physics.

[20]  V G Kiselev.  On the theoretical basis of perfusion measurements by dynamic susceptibility contrast MRI , 2001, Magnetic resonance in medicine.

[21]  Glyn Johnson,et al.  Measuring blood volume and vascular transfer constant from dynamic, T  2* ‐weighted contrast‐enhanced MRI , 2004, Magnetic resonance in medicine.

[22]  N. Sadato,et al.  H2150 Positron Emission Tomography Validation of Semiquantitative Prostate Blood Flow Determined by Double-Echo Dynamic MRI: A Preliminary Study , 2002, Journal of computer assisted tomography.

[23]  G S Karczmar,et al.  Differentiating between T1 and T2* changes caused by gadopentetate dimeglumine in the kidney by using a double‐echo dynamic MR imaging sequence , 1996, Journal of magnetic resonance imaging : JMRI.

[24]  K. Schmainda,et al.  Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. , 2008, Radiology.

[25]  K Sartor,et al.  Simultaneous assessment of cerebral hemodynamics and contrast agent uptake in lesions with disrupted blood-brain-barrier. , 1999, Magnetic resonance imaging.

[26]  P. Tofts,et al.  Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.

[27]  R W Cox,et al.  AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. , 1996, Computers and biomedical research, an international journal.

[28]  Thomas E Yankeelov,et al.  Variation of the relaxographic “shutter‐speed” for transcytolemmal water exchange affects the CR bolus‐tracking curve shape , 2003, Magnetic resonance in medicine.

[29]  J Sau,et al.  A model of the dual effect of gadopentetate dimeglumine on dynamic brain MR images , 1999, Journal of magnetic resonance imaging : JMRI.

[30]  T E Yankeelov,et al.  A theoretical framework to model DSC-MRI data acquired in the presence of contrast agent extravasation , 2009, Physics in medicine and biology.

[31]  Sang Hoon Lee,et al.  Simultaneous acquisition of perfusion and permeability from corrected relaxation rates with dynamic susceptibility contrast dual gradient echo. , 2004, Magnetic resonance imaging.

[32]  E F Halpern,et al.  Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. , 1994, Radiology.

[33]  B R Rosen,et al.  Echo-planar MR determination of relative cerebral blood volume in human brain tumors: T1 versus T2 weighting. , 1996, AJNR. American journal of neuroradiology.

[34]  Thomas E Yankeelov,et al.  Dynamic Contrast Enhanced Magnetic Resonance Imaging in Oncology: Theory, Data Acquisition, Analysis, and Examples. , 2007, Current medical imaging reviews.

[35]  B. D. Ward,et al.  Improving the reliability of obtaining tumor hemodynamic parameters in the presence of contrast agent extravasation , 2005, Magnetic resonance in medicine.

[36]  H. Kauczor,et al.  Assessment of Irradiated Brain Metastases by Means of Arterial Spin-Labeling and Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MRI: Initial Results , 2004, Investigative radiology.

[37]  R M Weisskoff,et al.  Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. , 2006, AJNR. American journal of neuroradiology.

[38]  J. Gore,et al.  Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model. , 2005, Magnetic resonance imaging.

[39]  D. D. Billheimer,et al.  Repeatability of a reference region model for analysis of murine DCE‐MRI data at 7T , 2006, Journal of magnetic resonance imaging : JMRI.

[40]  B. D. Ward,et al.  Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis. , 2004, AJNR. American journal of neuroradiology.

[41]  J A d'Arcy,et al.  Applications of sliding window reconstruction with cartesian sampling for dynamic contrast enhanced MRI , 2002, NMR in biomedicine.